SEC Form 4 · accession 0001209191-18-064353
Skye Bioscience, Inc. · SKYE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Emerald Health Sciences Inc.
10% Owner
Period of report
Dec 27, 2018
Accepted (ET)
Dec 28, 2018 · 6:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516551
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 27, 2018 | J | 37,667 | — | A | 73,153,917 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were issued pursuant to the conversion of accrued and unpaid interest on a convertible note, which is no longer outstanding, at the conversion price of $.10 per share.